Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    pipeline-prospector-insert-v1
    X

    Find Approved Oncology Drugs in Clinical Development in AUSTRALIA

    A collaboration with SCORR Marketing

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type

              Companies

              Cell Therapies

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              AUSTRALIA Australia

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              Pharma Nanotech & Nanomedicine

              Participation Not Confirmed

              Request a Meeting Now

              Novartis announces landmark steps for Kymriah® (tisagenlecleucel): reimbursement for adult DLBCL eligible patients and agreement to manuf...

              Contact the Supplier

              Lead Product(s): Tisagenlecleucel

              Therapeutic Area: Oncology

              Highest Development Status: Approved Product Type: Large molecule

              Partner/Sponsor/Collaborator: Novartis

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement January 28, 2020

              Details:

              Novartis has entered into an agreement with Cell Therapies to manufacture Kymriah at their production facility within the Peter MacCallum Cancer Centre in Melbourne.

              PharmaCompass__DigitalAd